Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... grants and contracts from the Department of Defense for development of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via ... monocytogenes, which Aduro scientists have genetically engineered to enhance both safety and efficacy. Listeria is an ideal delivery platform to enable the human immune system ...
2009 NOV 23 ... Pregnancy, Psychiatry, Public Health, Swine Flu, Swine Influenza, Vaccination, Vaccine Safety, Women's Health, Ohio State University. This article was prepared by ...
2009 NOV 24 ... their efforts during the 2009 H1N1 influenza outbreak and providing information on the safety of the 2009 H1N1 vaccines. "Some of your patients may be asking how the ...
2009 NOV 23 ... Food and Drug Administration has approved the use of CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only ... on a study of the company's seasonal flu vaccine in children showing the vaccine's safety and efficacy in inducing antibodies to protect against influenza. These efficacy ...
2009 NOV 23 ... NVAX) has begun a Phase IIa clinical study of its trivalent seasonal influenza VLP vaccine candidate in healthy adults 60 years of age or older. This randomized, double-blind, ... age or older. This randomized, double-blind, active-controlled study is evaluating the safety, tolerability and immunogenicity of two different doses of Novavax's trivalent seasonal ...
2009 NOV 29 ... vaccination rates varied widely across individual physicians (11-98 percent for PPV vaccine and 22-96 percent for influenza vaccine). They also found that longer reported ... Abortion in Family Medicine Practices Safe and Effective In a study validating the safety and efficacy of early abortion care by family physicians, researchers find the rates of ...
2009 NOV 24 ... countries, particularly in sub-Saharan Africa and Asia." "The need for a vaccine to reduce the number of deaths caused by rotavirus infection among children in ... colleagues. The researchers concluded: "However, studies addressing the safety, reactogenicity, and immunogenicity of rotavirus vaccines in an HIV-infected population ...
2009 NOV 26 ... Virus genetic sequences results in an HIV family tree that may lead researchers to new vaccine focus areas. NONLINEAR PHYSICS OF HIGH-POWERED LASERS Computer scientists ... Roadrunner system is now beginning its transition to classified computing to assure the safety, security, and reliability of the U.S. nuclear deterrent.Capitalizing on ...
2009 NOV 23 ... and cellular immunology have paved the way toward the rational design of an efficacious vaccine. We exploited self-cleaving peptide 2A from the foot-and-mouth disease virus, because of ... According to a study from Berlin, Germany, "Concerns about the safety and efficacy of Mycobacterium bovis bacillus Calmette-Guerin (BCG) emphasize the need ...
2009 NOV 16 ... The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial ... and thimerosol is 50% ethyl mercury, which has sparked a renewed debate on the safety of administering this new influenza vaccine. The purpose of the study was ...
2009 NOV 23 ... According to a study from New Delhi, India, "A rotavirus vaccine previously licensed in the United States was withdrawn because it caused ... rates in developing countries are required to plan pre- and postlicensure safety studies for new rotavirus vaccines." "Also, it is unclear whether natural ...
2009 NOV 16 ... published the results of their research in Oncology Reports (Enhancement of DNA cancer vaccine efficacy by combination with anti-angiogenesis in regression of established subcutaneous ... combining cancer vaccination with angiogenesis inhibition is appealing, due to favorable safety profile of both approaches, as well as possible biological synergies." ...
2009 NOV 16 ... Infectious Disease, Measles, Pediatrics, Public Health, Swine Flu, Swine Influenza, Vaccine Safety, Virology. This article was prepared by Pharma Business Week editors from ...
2009 NOV 16 ... A pivotal efficacy trial of RTS,S, the world's most clinically advanced malaria vaccine candidate, is now underway in seven African countries: Burkina Faso, Gabon, Ghana, ... this future and are participating to ensure that we develop a vaccine with an acceptable safety and efficacy profile." RTS,S is the first vaccine designed primarily for ...
2009 NOV 16 ... over 33 million people estimated to be living with HIV worldwide. No cure or effective vaccine yet exists. Current treatment regimens are based on combinations of different classed of ... cells infected with the HIV virus and eliminate them. This first study will evaluate safety and the right dose of these cells needed to be effective." According to ...
